Worldwide epidemiology of chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 2, 1999, Pages 93-99

  Chen, Joyce C ^a   Mannino, David M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; FEMALE; HUMAN; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; REVIEW; RISK FACTOR; SMOKING CESSATION;

ADOLESCENT; ADULT; COST OF ILLNESS; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; RISK FACTORS; SMOKING CESSATION;

EID: 0033086045     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199903000-00003     Document Type: Article

References (55)

1. Rennard SI: COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 1998, 113(suppl):235S-241S. A useful review of the etiology and progression of COPD, focusing on the process of loss of lung function, the results of the Lung Health Study, and the challenges of smoking prevention and cessation.
2. Petty TL, Weinmann GG: Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute workshop summary. JAMA 1997, 277:246-253.
3. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152(suppl):S77-S120.
4. Coultas DB: Health effects of passive smoking: 8. Passive smoking and risk of adult asthma and COPD: an update. Thorax 1998, 53:381-387.
5. Petty TL: Definitions in chronic obstructive pulmonary disease. Clin Chest Med 1990, 11:363-373.
6. James AL, Pare PD, Hogg JC: The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989, 139:242-246.
7. Silverman EK, Speizer FE: Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996, 80:501-522.
8. US Surgeon General: The health consequences of smoking: chronic obstructive lung disease. Washington, DC: US Department of Health and Human Services; 1984. [DHHS publication no. 84-50205.]
9. Bresnitz EA: Epidemiology of advanced lung disease in the United States. Clin Chest Med 1997, 18:421-433. A review of national data, with an emphasis on health care utilization figures. Includes not only COPD but also cystic fibrosis, sarcoidosis, the pneumoconioses, idiopathic pulmonary fibrosis, and primary pulmonary hypertension.
10. Kerstjens HAM, Rijcken B, Schouten JP, Postma DS: Decline of FEV, by age and smoking status: facts, figures, and fallacies. Thorax 1997, 52:820-827.
11. 1. JAMA 1994, 272:1497-1505.
12. Lam TH, He Y, Li LS, Li LS, He SF, Liang BQ: Mortality attributable to cigarette smoking in China. JAMA 1997, 278:1505-1508.
13. Chen Z, Xu Z, Collins R, Li W, Peto R: Early health effects of the emerging tobacco epidemic in China. JAMA 1997, 278:1500-1504.
14. Archibald CP, Lee HP: Smoking-associated mortality in a cohort of Singaporeans observed for 20 years. Ann Acad Med Singapore 1996, 25:123-128.
15. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr: Mortality from Smoking in Developed Countries 1950-2000. Oxford: Oxford University Press; 1994.
16. Hendrick DJ: Occupational lung disease: 9. Occupation and chronic obstructive pulmonary disease. Thorax 1996, 51:947-955.
17. Becklake MR: Chronic airflow limitation: its relationship to work in dusty occupations. Chest 1985, 88:608-616.
18. Coggon D, Taylor AN: Coal mining and chronic obstructive pulmonary disease: a review of the evidence. Thorax 1998, 53:398-407.
19. Fishwick D, Bradshaw LM, D'Souza W, Town I, Armstrong R, Pearce N, Crane J: Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med 1997, 156:1440-1446.
20. Ray D, Abel R, Selvaraj KG: A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian J Med Res 1995, 101:238-244.
21. Amoli K: Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. Eur Respir J 1998, 11:659-663.
22. Behera D, Jindal SK: Respiratory symptoms in Indian women using domestic cooking fuels. Chest 1991, 100:385-388.
23. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G: Wood smoke exposure and risk for obstructive airways disease among women. Chest 1996, 109(suppl):55S-56S.
24. Xu X, Rijcken B, Schouten JP, Weiss ST: Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997, 350:1431-1434.
25. Sherrill DL, Enright P, Cline M, Burrows B, Lebowitz MD: Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996, 109:1001-1005.
26. Tashkin DP, Clark VA, Coulson AH, Simmons M, Bourque LB, Reems C: The UCLA population studies of chronic obstructive respiratory disease: VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis 1984, 130:707-715.
27. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD: Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987, 135:794-799.
28. Dockery DW, Speizer FE, Ferris BG Jr, Ware JH, Louis TA, Spiro A III: Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis 1988, 137:286-292.
29. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F: Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Eur Respir J 1988, 1:311-318.
30. Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Jensen G: Decline of the lung function related to the type of tobacco smoked and inhalation. Thorax 1990, 45:22-26.
31. Kauffmann F, Tessier JF, Oriol P: Adult passive smoking in the home environment: a risk factor for chronic airflow limitation. Am J Epidemiol 1983, 117:269-280.
32. Chen Y, Home SL, Dosman JA: Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991, 143:1224-1230.
33. Xu X, Li B, Wang L: Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994, 7:477-483.
34. 1: new insight into gender differences. Eur Respir J 1994, 7:1056-1061.
35. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW: Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996, 335:931-937.
36. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997, 10:822-827.
37. 1-antitrypsin deficiency remains the only established genetic risk factor, but research into genetic predictors and modifiers of COPD risk continues to grow.
38. Dockery DW, Ware JH, Ferris BG Jr, Glicksberg DS, Fay ME, Spiro A III: Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis 1985, 131:511-520.
39. Burrows B, Lebowitz MD, Camilli AE, Knudson RJ: Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis 1986, 133:974-980.
40. Ware JH, Dockery DW, Louis TA, Xu XP, Ferris BG Jr, Speizer FE: Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol 1990, 132:685-700.
41. Glindmeyer HW, Lefante JJ, McColloster C, Jones RN, Weill H: Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. Am J Respir Crit Care Med 1995, 151:412-422.
42. Brandli O, Schindler C, Kunzli N, Keller R, Perruchoud AP: Lung function in healthy never smoking adults: reference values and lower limits of a normal of a Swiss population. Thorax 1996, 51:277-283.
43. Burrows B, Knudson RJ, Camilli AE, Lyle SK, Lebowitz MD: The 'horse-racing effect' and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 1987, 135:788-793.
44. Wise RA: Changing smoking patterns and mortality from chronic obstructive pulmonary disease. Prev Med 1997, 26:418-421.
45. Ventura SJ, Peters KD, Martin JA, Maurer JD: Births and Deaths, United States, 1996: Monthly Vital Statistics Report, vol. 46 no. 1, suppl. 2. Hyattsville, MD: National Center for Health Statistics; 1997.
46. Centers for Disease Control and Prevention: Mortality patterns: preliminary data, United States, 1996. MMWR Morbid Mortal Wkly Rep 1997, 46:941-944.
47. Mannino DM, Brown C, Giovino GA: Obstructive lung disease deaths in the United States from 1979 through 1993. Am J Respir Crit Care Med 1997, 156:814-818. An analysis using Multiple-Cause Mortality Files to describe national trends in deaths related to obstructive lung diseases over this 15-year period, because previous studies using only underlying cause of death data likely underestimated these figures. Mortality patterns varied by gender, race, and age, but overall, the age-adjusted mortality rate associated with COPD increased by 17.1% for men and 126.1% for women during this period.
48. Menotti A, Blackburn H, Seccareccia F, Kromhout D, Nissinen A, Aravanis C, et al.: The relation of chronic disease to all-cause mortality risk: the Seven Countries Study. Ann Med 1997, 29:135-141.
49. World Health Organization: World Health Statistics Annual, 1995. Geneva: World Health Organization; 1995.
50. Morano MA: Current Estimates From the National Health Interview Survey, 1994. Washington, DC: National Center for Health Statistics, US Government Printing Office; 1996. [DHHS publication no. (PHS) 96-1521, Vital and Health Statistics, series 10, no. 193].
51. National Heart, Lung, and Blood Institute: Morbidity and Mortality: 1996 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 1996.
52. Whittemore AS, Perlin SA, DiCiccio Y: Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES. Am J Public Health 1995, 85:702-706.
53. The National Lung Health Education Program Executive Committee: Strategies in preserving lung health and preventing COPD and associated diseases: the National Lung Health Education Program (NLHEP). Chest 1998, 113(suppl):123S-163S.
54. Keistinen T, Vilkman S, Tuuponen T, Kivela S-L: Hospital admissions for chronic obstructive pulmonary disease in the population aged 55 years or over in Finland during 1972-1992. Scand J Soc Med 1997, 25:238-242.
55. Sheffer AL, Taggart VS: The National Asthma Education Program: expert panel report guidelines for the diagnosis and management of asthma. Med Care 1993, 31(suppl):MS20-MS28.